Videos / Managing atherogenic dyslipidaemia and diabetic retinopathy in type 2 diabetes
Product Explainer
Managing atherogenic dyslipidaemia and diabetic retinopathy in type 2 diabetes
Description
In this Product Explainer, Endocrinologist Prof Richard O’Brien explains the role of Fenofibrate in reducing the progression of diabetic retinopathy in patients with type 2 diabetes (5 mins).
NEXT LIVE Webcast
:
Days
:
Hours
:
Minutes
Seconds
Dr Rupert Hinds
Functional Gastrointestinal Disorders in Infants – Practical Advice for HCPs
Dr Shannon Thomas
TIAs and Carotid Stenosis
Dr Ginni Mansberg
Low libido - What is it & How is it Managed?
A/Prof Michael Woodward AM
Using the New RSV Vaccine in Practice
Join us for the next free webcast for GPs and healthcare professionals
High quality lectures delivered by leading independent experts
Endocrinologist; Clinical Dean of Medicine, University of Melbourne, Austin Clinical School; Director of Graduate Programs, Melbourne Medical School; Senior Endocrinologist and Director, Lipid Service, Austin Health
